Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection

…, M Kloss, T Mizutani, K Minematsu… - The Lancet …, 2015 - thelancet.com
Spontaneous intracranial artery dissection is an uncommon and probably underdiagnosed
cause of stroke that is defined by the occurrence of a haematoma in the wall of an intracranial …

Good laboratory practice: preventing introduction of bias at the bench

…, HB Van Der Worp, R Traystman, K Minematsu… - Stroke, 2009 - Am Heart Assoc
Background and Purpose— As a research community, we have failed to demonstrate that
drugs which show substantial efficacy in animal models of cerebral ischemia can also improve …

Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan …

K Minematsu, K Toyoda, T Hirano, K Kimura… - Journal of Stroke and …, 2013 - Elsevier
In Japan, intravenous alteplase, a recombinant tissue-type plasminogen activator (rt-PA),
was approved for an indication of ischemic stroke in 2005 on the basis of the results of a …

Predisposing factors to enlargement of spontaneous intracerebral hematoma

S Kazui, K Minematsu, H Yamamoto, T Sawada… - Stroke, 1997 - Am Heart Assoc
Background and Purpose Enlargement of intracerebral hemorrhage is a major cause of
clinical deterioration. Identification of factors that predispose to hematoma enlargement is …

Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT)

…, E Mori, K Minematsu, J Nakagawara, K Hashi… - Stroke, 2006 - Am Heart Assoc
… 2 Kimura K, Kazui S, Minematsu K, Yamaguchi T; for the Japan Multicenter Stroke
Investigators’ Collaboration (J-MUSIC). Analysis of 16922 patients with acute ischemic stroke and …

[HTML][HTML] Ticagrelor versus aspirin in acute stroke or transient ischemic attack

…, P Held, J Jonasson, K Minematsu… - … England Journal of …, 2016 - Mass Medical Soc
Background Ticagrelor may be a more effective antiplatelet therapy than aspirin for the
prevention of recurrent stroke and cardiovascular events in patients with acute cerebral ischemia. …

Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention …

A Ogawa, E Mori, K Minematsu, W Taki, A Takahashi… - Stroke, 2007 - Am Heart Assoc
Background and Purpose— The Middle Cerebral Artery Embolism Local Fibrinolytic
Intervention Trial (MELT) Japan was organized to determine the safety and clinical efficacy of …

Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke

K Kimura, K Minematsu, T Yamaguchi - Journal of Neurology …, 2005 - jnnp.bmj.com
Background: Atrial fibrillation (AF) is a common arrhythmia and a major risk factor for stroke.
Aims: To assess whether AF in patients with acute ischaemic stroke is associated with …

Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes

…, C Yokota, H Moriwaki, H Naritomi, K Minematsu - Neurology, 2008 - AAN Enterprises
Objective: The NIH Stroke Scale (NIHSS) may not appropriately assess the spectrum of
posterior circulation (PC)–related neurologic deficits. We determined the cutoff baseline NIHSS …

: a lightweight block cipher for multiple platforms

T Suzaki, K Minematsu, S Morioka… - … Conference on Selected …, 2012 - Springer
… , we employ the idea of Suzaki and Minematsu at FSE ’10 [42] … π comes from a result of
Suzaki and Minematsu [42]. In [42], it … DRmax of cyclic shift with k subblocks is k, while there exist …